PL Warrant Dilution Hits Amid $17.9M in Insider Sales

NEW YORK, May 10 —

Planet Labs PBC filed an 8-K on May 4 disclosing a warrant redemption event — warrants converting into new common shares — that sent the stock down roughly 9% in a single session. The filing landed weeks after SEC records showed the CEO, CFO, and co-founder had sold a combined $17.86M in open-market shares at $33.91 to $35.22. Planet Labs (PL) now trades at $39.04, 11% above the analyst consensus price target of $35.22. The executives who know the business best sold at prices the stock has since left behind.

The Selling Pattern

The insider activity reads like a coordinated exit — though the disclosure forms don't indicate whether these were pre-planned 10b5-1 trades. Over early April, four Planet Labs officers cashed out across a narrow price band. CEO William Spencer Marshall sold 200,000 shares at $35.07 on April 6, generating $7.01M. President and CFO Ashley F. Johnson moved 200,000 shares in two tranches on April 2 — 51,460 shares at $34.76 ($1.79M) and 148,540 at $35.22 ($5.23M) — for a combined $7.02M. Co-founder and Chief Strategy Officer Robert H. Schingler sold 73,683 shares at $35.07 on April 6 for $2.58M. Insider Ita M. Brennan added 36,500 shares at $33.91 on April 15 for $1.24M.

In total, across the 90-day Form 4 window, insiders recorded $17.86M in net open-market sales with zero purchases. That the CFO — who sees every line of the company's books — sold at the top of this cluster matters. So does the fact that all four transactions cleared below the stock's current price of $39.04. Either the insiders left performance on the table, or the stock has since moved ahead of fundamentals.

The Dilution Hit

The May 4 8-K filing (Items 8.01 and 9.01) disclosed a warrant redemption event under which warrants are converting into new common shares. Warrant conversions mechanically increase share count, diluting existing shareholders' percentage ownership and prompting warrant holders to sell their newly received shares immediately. The market's reaction was swift: PL fell roughly 9% in the session following the announcement. A 9% single-day drop on a dilution filing suggests the share-count math caught investors off guard.

The Growth Case

None of this changes the underlying numbers. Planet Labs reported TTM revenue of approximately $310M growing at 41.1% year-over-year, with a gross margin of 56.2%. The company beat consensus EPS estimates in each of the three most recently reported quarters: posting breakeven ($0.00) when analysts expected a loss of roughly $0.04; then -$0.03 against an estimate of about -$0.05; and breakeven again versus an estimate of around -$0.04. Three straight beats above consensus mean management is controlling costs better than Wall Street expected, and the trend is hard to dismiss.

See the full DCF model and price target →

Priced Above the Consensus

The problem isn't the business — it's the price. At $39.04, PL trades 11% above the analyst consensus price target of $35.22. That's an unusual position for a stock facing fresh dilution from warrant conversions, with senior insiders having sold every open-market share in the last 90 days at prices between $33.91 and $35.22. The combination of a premium to consensus, a near-term dilution overhang, and $17.86M of insider selling with no offsetting purchases puts buyers at $39.04 on the wrong side of all three signals. The growth story is intact. The entry point is not.

The next checkpoint: the total share-count impact from the warrant conversion and whether management addresses the dilution in the next earnings call. A formal guidance revision — or an insider purchase at current prices — would shift the calculus. Until then, the stock is running ahead of both the analysts who cover it and the executives who know it best.

Basis Report does not hold positions in securities discussed. This is not investment advice.

Frequently Asked Questions

Why did Planet Labs stock drop recently?

PL fell approximately 9% in a single session after the company filed an 8-K on May 4, 2026 disclosing a warrant redemption that converts outstanding warrants into new common shares. New shares hit the float immediately, increasing the share count and prompting warrant holders to sell their newly received equity. That combined selling pressure drove the decline.

Are Planet Labs insiders selling shares?

ween April 2 and April 15, 2026, at prices ranging from $33.91 to $35.22 per share. No open-market purchases were recorded in the same 90-day reporting window. The net position is clear: insiders sold, nobody bought.

What is a warrant redemption and why does it hurt Planet Labs stock?

A warrant redemption converts outstanding warrants into new common shares, increasing the total share count and diluting existing shareholders' percentage ownership of the company. Planet Labs disclosed this event in a May 4, 2026 SEC filing, and the stock fell approximately 9% in the following session as investors absorbed the higher share count.

Is Planet Labs stock overvalued at $39?

At $39.04, PL trades 11% above the analyst consensus price target of $35.22. Senior insiders sold open-market shares at $33.91 to $35.22 in April — prices that now sit well below the current market price. That gap, combined with fresh warrant dilution, puts buyers at $39.04 behind three negative signals despite strong underlying fundamentals.

What is Planet Labs' revenue growth rate?

Planet Labs reported trailing twelve-month revenue of approximately $310M, growing 41.1% year-over-year with a gross margin of 56.2%. The company also beat consensus EPS estimates in each of its three most recently reported quarters, showing consistent progress toward profitability.